Month one
Assess & start
History, vitals, labs and RMR testing. Consent reviewed, starting dose selected, and nutrition and hydration targets set.
Medical weight management
GLP-1 therapy, built around your metabolism.
Semaglutide and tirzepatide work best when the plan around them is right. We measure your resting metabolic rate, set protein and calorie targets you can actually hit, and titrate slowly enough to keep side effects manageable and muscle intact.
How it works
Appetite is biology. We treat it that way.
GLP-1 receptor agonists slow gastric emptying, quiet food noise and improve glycemic control. Administered by weekly subcutaneous injection and titrated over months, they make a sustainable calorie deficit possible instead of exhausting. What they do not do is replace protein, resistance training or sleep — so those are written into your plan from day one.
Every program is supervised by our physician assistant, with dose changes based on your response, tolerance and labs — never a fixed script.
You may be a candidate if
- BMI of 30+, or 27+ with a weight-related condition
- Weight that has plateaued despite consistent effort
- Insulin resistance, prediabetes or PCOS-related weight gain
- Willingness to attend follow-ups and complete lab work
Included in the program
More than a prescription and a scale.
Months two to four
Titrate & protect
Stepwise dose increases with side-effect coaching, protein and resistance-training targets, and repeat RMR to confirm metabolism is holding.
Beyond
Maintain
Tapering strategy, maintenance dosing where appropriate, and a plan for keeping the result once therapy changes or stops.
- Baseline medical evaluation, medication review and lab work
- KORR resting metabolic rate measurement to set real calorie targets
- Weekly GLP-1 / GIP therapy with structured dose titration
- Protein, fiber and hydration targets to protect lean muscle
- Side-effect management and scheduled follow-up visits
- Gut health and micronutrient support alongside therapy
GLP-1 therapy is not appropriate for everyone. It is contraindicated in pregnancy and with a personal or family history of medullary thyroid carcinoma or MEN2, and requires caution with pancreatitis, gallbladder or gastrointestinal disease. Risks, monitoring and program terms are detailed in the GLP-1 consent form available on the patient forms page.
Consent forms
Download your weight management paperwork
Read the GLP-1 consent in full before your first injection — it covers titration, monitoring and the warnings that matter most.
Pre & post-treatment instructions
What to do in the days before your appointment and how to care for your skin afterwards. Read this first, whatever you are booking.
PDF · 112 KBGeneral consent, privacy & financial policy
New-patient consent to evaluate and treat, HIPAA privacy acknowledgement, photography permission and the cancellation policy.
PDF · 46 KBGLP-1 medical weight management consent
Semaglutide and tirzepatide therapy: titration, monitoring, side effects, thyroid and pregnancy warnings and program terms.
PDF · 46 KBStart with a number, not a guess.
Book a weight management consultation with metabolic testing and we'll build the plan from your data.